
|Articles|September 20, 2019
Challenges and Barriers to 503B Compounding
Ernest P. Gates Jr., president, CEO, Gates Healthcare Associates, lays out some of the biggest hurdles to bulk compounding.
Advertisement
Ernest P. Gates Jr., president, CEO, Gates Healthcare Associates, lays out some of the biggest hurdles to bulk compounding.
Newsletter
Pharmacy practice is always changing. Stay ahead of the curve with the Drug Topics newsletter and get the latest drug information, industry trends, and patient care tips.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Drug Topics
1
FDA Approves Enflonsia for the Prevention of RSV Lower Respiratory Tract Disease in Infants
2
The Emergence of CGRP-Targeted Therapies is Transforming Migraine Care | NCPA 2025
3
Pharmacists Experience Challenges in Credentialing, Billing for Services | NCPA 2025
4
American Pharmacists Month: Pharmacies Expanding Clinical Services Amid Network, Access Challenges
5